genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Marburg virus
      Drug Discovery

      First-In-Human Trial of Marburg Vaccine Shows Promising Results

      Infectious Disease Diagnostics

      Exploring Ways to Block Malaria Transmission

      measles virus
      Infectious Diseases

      Collective Measles Virus Mutations Linked to Fatal Encephalitis

      Bioprocessing

      Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

      Blood cells
      Infectious Diseases

      Repeated Malaria Expands Innate Immune Cell-Type in Ugandan Children

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      blood cells
      Blood Disorders

      Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

      Artificial Intelligence

      Chiral Spectroscopy Lessens the Chiral Resolution Stumbling Block

      Antibodies

      Advanced Therapies Could Be Sleepwalking into a Manufacturing Cost Crisis

      Bioprocessing

      Cell and Gene Therapy Scale-Up Challenges

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Companies GlaxoSmithKline

GlaxoSmithKline

  • 23andMe
  • Abbvie
  • AdnaGen
  • Agilent Technologies
  • Alexion Pharmaceuticals
  • Amgen
  • Astellas
  • AstraZeneca
  • Audentes Therapeutics
  • Berkeley Lights
  • Bio-Rad Laboratories
  • Biogen
  • Cancer Genetics
  • Catalent
  • Charles RIver Laboratories
  • Dana-Farber Cancer Institute
  • deCODE genetics
  • Dicerna
  • Dimension Therapeutics
  • Exact Sciences
  • Foundation Medicine
  • GE Healthcare
  • GeneInsight
  • Gilead Sciences
  • GlaxoSmithKline
  • Halozyme Therapeutics
  • Hitachi High-Technologies
  • Horizon Discovery Group
  • Human Longevity
  • Illumina
  • Jackson Laboratory
  • Janssen Biotech
  • LabCorp
  • Maravai LifeSciences
  • MD Anderson
  • MDxHealth
  • MedImmune
  • Memorial Sloan Kettering Cancer Center
  • Merck & Co
  • Merck KGaA
  • NanoString Technologies
  • Novartis
  • Pathology
  • PerkinElmer
  • PersonalizeDx
  • Qiagen
  • RayBiotech
  • Roche
  • Sanofi
  • shire
  • Sigma-Aldrich
  • Synthego
  • Takeda
  • Thermo Fisher Scientific
  • UCB Biosciences
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Infectious Diseases

    StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

    GEN 40

    StockWatch: After Bluebird’s Second Approval, Investors Are Looking for More

    Coronavirus

    StockWatch: Novavax Sinks with Revenue Forecast, Vaccine Demand

    Vaccine Development

    GSK to Acquire Affinivax for Up to $3.3B, Bolstering Vaccine Portfolio

    Oncologics

    StockWatch: Sierra Oncology Surges on $1.9B GSK Acquisition

    HBV

    And Then There Were Four: VBI Scores First FDA Approval with...

    GlaxoSmithKline

    U.S. OKs EUA for Genentech’s Actemra vs. COVID-19; Halts Distribution of...

    GlaxoSmithKline

    GSK, Vir Seek Emergency Use Authorization for COVID-19 Antibody

    GlaxoSmithKline

    Sanofi, GSK Launch Phase II Trial of “Refined” COVID-19 Vaccine

    Horizontal DNA Double Helixx
    GlaxoSmithKline

    DARPA to Fund CRISPR Diagnostics Using Mammoth, IDbyDNA Technologies

    GlaxoSmithKline

    NVIDIA Powers Up in Drug Discovery

    GlaxoSmithKline

    As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19...

    GlaxoSmithKline

    Sanofi, GSK Advance COVID-19 Vaccine into the Clinic

    GlaxoSmithKline

    At Orchard, Moving from Pruning to Planting

    GlaxoSmithKline

    GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates

    1234Page 1 of 4

    Recently Featured

    Exploring Ways to Block Malaria Transmission

    Exploring Ways to Block Malaria Transmission

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    First-In-Human Trial of Marburg Vaccine Shows Promising Results

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Sustained Graft-Versus-Host Disease Depends on Tissue-Resident Seeds

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Catalent Opens New Commercial-Scale Plasmid DNA Manufacturing Facility

    Read the Digital Edition

    GEN 2022 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up